Nimml institute presents pioneering research on immunometabolic mechanisms related to the pharmacological activation of lancl receptors at immunology2024, the annual meeting of the american association of immunologists

Blacksburg, va.--(business wire)--the nimml institute, (“nimml”), a 501 (c)(3) nonprofit institute dedicated to the discovery of novel precision medicines for infectious and autoimmune diseases, today announced that it will present four abstracts regarding novel mechanistic insights related to the pharmacological activation of lancl receptors at immunology2024, the 107th annual meeting of the american association of immunologists (“aai”). the aai meeting will take place at mccormick place in ch.
SLE Ratings Summary
SLE Quant Ranking